Skip to content
Search

Latest Stories

Boots partners with LIVI to strengthen its digital pharmacy services

Boots UK on Thursday (16) announced a new partnership with digital healthcare provider LIVI to strengthen its digital pharmacy services.

The existing Boots UK and LIVI collaboration of in-store services is expanding as trial of a new online GP and pharmacy video consultation service begins.


The trial has been brought forward to assist patients isolating due to the Covid-19 pandemic.

Richard Bradley, Director of Pharmacy for Boots UK, said: “With millions of patients self-isolating at home – particularly the elderly or those with underlying health conditions – access to expert health advice without having travel to a pharmacy or GP surgery is even more crucial.

“We are pleased to work with innovators like LIVI to continue transforming online and high street access to healthcare advice, medical services and medicines.”

The companies are working together through approved and regulated routes to trial how patients could remotely access a Boots pharmacist via the LIVI app, to get general health advice and to have a conversation face-to-face about their own prescription medications.

This service has the potential to help reduce pressure on the NHS, ensuring that customers maintain simple and safe access to healthcare whilst at home.

The partnership will also see a future expansion of the successful in-store pilot to several new Boots UK stores – the majority of which will deliver NHS commissioned services – in high street locations throughout the country.

Juliet Bauer, UK Managing Director, LIVI, said: “Boots UK shares our ethos that the health system should be responsive to the needs of patients. By tapping into our digital health tech, millions of Boots UK customers will be able to access a more responsive and flexible health service.”

The long-term agreement follows the successful pilot programme in two Boots stores from October 2019. These stores will offer the LIVI video GP service via a tablet in-store, as well as a range of diagnostic tools, such as blood pressure monitoring.

More For You

GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less
Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
CPCF negotiations: CPE working to secure the best outcomes for the sector
Pharmacy sector demands urgent resolution of CPCF negotiations (gettyimages)

CPCF Negotiations: CPE unable to share details until official announcement

Acknowledging the sector's urgent need to resolve CPCF negotiations, CPE reiterates its commitment to securing the best possible outcome

Community Pharmacy England (CPE) has provided an update on the ongoing 2024/25 and 2025/26 Community Pharmacy Contractual Framework (CPCF) negotiations with the Department of Health and Social Care (DHSC) and NHS England.

“The Negotiating Team are continuing in-depth negotiations with DHSC and NHS England,” the Committee said, adding that they are focused on securing the “best outcomes” for pharmacy owners.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less